3D Global Biotech Inc. (TPEX:6808)

3D Global Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	55.49	56.12	21.82	15.53	20.37	8.43
Short-Term Investments	714.88	647.74	144.2	192.9	212.8	268.3
Cash & Short-Term Investments	770.37	703.86	166.02	208.43	233.17	276.73
Cash Growth	125.63%	323.97%	-20.35%	-10.61%	-15.74%	-6.77%
Accounts Receivable	31.35	119.58	1.35	1.09	1.23	1.61
Other Receivables	1.04	2.99	0.59	0.44	0.41	0.67
Receivables	32.38	122.57	1.94	1.53	1.64	2.28
Inventory	37.61	7.04	3.6	3.37	0.88	1.14
Other Current Assets	-	2.34	4.12	2.68	4.15	1.08
Total Current Assets	851.48	835.81	175.67	216.01	239.85	281.23
Property, Plant & Equipment	97.71	92.77	13.15	21.02	28.17	28.9
Other Intangible Assets	80.42	87.79	102.29	117.09	152.3	168.62
Long-Term Deferred Tax Assets	26.08	18.56	16.27	15.31	3.2	3.16
Other Long-Term Assets	2.44	2.65	16.77	1.84	0.99	0.67
Total Assets	1,058	1,038	324.15	371.26	424.52	482.57
Accounts Payable	1.17	16.08	3.33	2.22	0.67	0.93
Accrued Expenses	-	14.34	7.69	7.61	6.35	5.31
Current Portion of Leases	8.94	11	6.3	6.37	5.5	4.09
Current Unearned Revenue	6.09	6.63	7.31	2.22	-	-
Other Current Liabilities	58.91	4.41	1.87	1.74	2.44	1.57
Total Current Liabilities	75.1	52.46	26.49	20.17	14.95	11.9
Long-Term Leases	77.56	73.77	4.08	10.38	15.81	16.7
Long-Term Deferred Tax Liabilities	-	6.65	-	-	3.94	5.16
Other Long-Term Liabilities	-	-	0.11	0.11	0.11	-
Total Liabilities	152.66	132.88	30.68	30.66	34.81	33.75
Common Stock	778.4	778.4	568.09	557.4	539.7	539.7
Additional Paid-In Capital	36.17	34.59	1.22	2.08	1.8	1.61
Retained Earnings	90.9	91.7	-275.84	-218.88	-151.79	-92.49
Shareholders' Equity	905.47	904.69	293.47	340.6	389.71	448.82
Total Liabilities & Equity	1,058	1,038	324.15	371.26	424.52	482.57
Total Debt	86.5	84.76	10.38	16.75	21.31	20.78
Net Cash (Debt)	683.87	619.1	155.64	191.68	211.87	255.95
Net Cash Growth	104.56%	297.78%	-18.80%	-9.53%	-17.22%	-12.98%
Net Cash Per Share	8.35	8.75	2.77	3.49	3.93	4.78
Filing Date Shares Outstanding	77.81	77.84	56.81	55.74	53.97	53.97
Total Common Shares Outstanding	77.81	77.84	56.81	55.74	53.97	53.97
Working Capital	776.38	783.35	149.17	195.84	224.9	269.34
Book Value Per Share	11.64	11.62	5.17	6.11	7.22	8.32
Tangible Book Value	825.05	816.91	191.18	223.52	237.41	280.2
Tangible Book Value Per Share	10.60	10.49	3.37	4.01	4.40	5.19
Machinery	-	20.25	14.61	14.38	13.77	10.94
Leasehold Improvements	-	13.15	12.57	12.57	12.57	12.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.